At stake are generics of biological drugs that are used to treat various diseases such as cancer and autoimmune diseases. The access to more information and the existence of rules by entities of the Ministry of Health can lead to an increase in its use, concludes a study by the National School of Public Health.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.